Sequana Medical NV
XBRU:SEQUA
Sequana Medical NV
XBRU:SEQUA
Price:
1.12
EUR
0.9%
Market Cap:
59.2m
EUR
Balance Sheet
Balance Sheet Decomposition
Sequana Medical NV
Sequana Medical NV
| Current Assets | 6.4m |
| Cash & Short-Term Investments | 3.8m |
| Receivables | 563k |
| Other Current Assets | 2m |
| Non-Current Assets | 3.5m |
| Long-Term Investments | 104k |
| PP&E | 3.4m |
Balance Sheet
Sequana Medical NV
Sequana Medical NV
Currency: EUR
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
1
|
6
|
11
|
10
|
19
|
3
|
4
|
|
| Cash Equivalents |
1
|
1
|
2
|
1
|
6
|
11
|
10
|
19
|
3
|
4
|
|
| Total Receivables |
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
2
|
2
|
1
|
1
|
2
|
1
|
2
|
3
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
4
|
3
|
3
|
3
|
9
|
13
|
13
|
23
|
6
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
4
-19%
|
4
-8%
|
3
-5%
|
9
+180%
|
14
+52%
|
15
+3%
|
26
+77%
|
10
-61%
|
10
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
|
| Accrued Liabilities |
1
|
1
|
0
|
3
|
1
|
1
|
3
|
4
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
3
|
12
|
1
|
0
|
0
|
5
|
8
|
40
|
|
| Other Current Liabilities |
2
|
2
|
1
|
2
|
2
|
2
|
2
|
4
|
5
|
9
|
|
| Total Current Liabilities |
4
|
5
|
6
|
19
|
5
|
6
|
7
|
15
|
19
|
53
|
|
| Long-Term Debt |
0
|
5
|
2
|
3
|
3
|
8
|
8
|
13
|
9
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
|
| Total Liabilities |
5
N/A
|
10
+111%
|
8
-22%
|
22
+172%
|
8
-62%
|
14
+67%
|
15
+10%
|
28
+82%
|
30
+5%
|
54
+84%
|
|
| Equity | |||||||||||
| Common Stock |
4
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
5
|
|
| Retained Earnings |
54
|
63
|
71
|
85
|
102
|
121
|
145
|
176
|
209
|
251
|
|
| Additional Paid In Capital |
49
|
55
|
65
|
65
|
101
|
119
|
142
|
170
|
186
|
202
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
0
N/A
|
7
-2 242%
|
5
+31%
|
19
-307%
|
1
N/A
|
0
-88%
|
1
N/A
|
2
-174%
|
19
-804%
|
44
-128%
|
|
| Total Liabilities & Equity |
5
N/A
|
4
-19%
|
4
-8%
|
3
-5%
|
9
+180%
|
14
+52%
|
15
+3%
|
26
+77%
|
10
-61%
|
10
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
13
|
13
|
16
|
19
|
24
|
28
|
44
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
